Atricure Inc. buy stratec
Start price
12.04.19
/
50%
€25.43
Target price
04.11.21
€66.00
Performance (%)
15.17%
End price
05.11.21
€29.29
Summary
This prediction ended on 05.11.21 with a price of €29.29. The prediction had a final performance of 15.17%. stratec has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Atricure Inc. | -1.681% | -1.681% | -62.258% | -62.258% |
| iShares Core DAX® | 2,55 % | 0,56 % | 14,14 % | 49,14 % |
| iShares Nasdaq 100 | 2,74 % | -0,60 % | 30,37 % | 82,05 % |
| iShares Nikkei 225® | 6,58 % | 4,34 % | 49,37 % | 60,62 % |
| iShares S&P 500 | 1,93 % | -0,51 % | 24,26 % | 59,66 % |
Comments by stratec for this prediction
In the thread Atricure Inc. diskutieren
stratec stimmt dem Sentiment von 'Sell' nicht zu
The stock got an Overweight rating with a $37 price target at JP Morgan. Morgan's analyst list three key reasons he likes the shares at current trading levels.
- The valuation is attractive and the name offers durable organic mid-teens top-line growth.
- Has a favorable view on the lack of competitors.
- Sees catalysts from COVERAGE data over the coming 1-year period.
Kursziel geändert auf 46,0
Kursziel geändert auf 66,0
In the thread Trading Atricure Inc.
Die von stratec gewählte maximale Laufzeit wurde überschritten